| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.3 |